Delivery Order SPE2DB24D2101-SPE2DB25FKGHU

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,869.89, is a Firm Fixed Price Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET medical products. The contract has an ultimate completion date of January 17, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,189.79, is for the delivery of BIKTARVY 50-200-25 MG TABLET in units of 30 tablets. This is a Firm Fixed Price Delivery Order contract with a completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of BIKTARVY 50-200-25 MG TABLET medical supplies. The contract has a total ceiling value of $22,388.25 and a performance period running through January 15, 2025. The contract is a delivery order, with a firm fixed-price pricing type. There is no set-aside designation for this award. AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions...
This $71,221.86 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,514.16 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of BIKTARVY 50-200-25 MG TABLET medical products. The award has a ceiling value of $14,694.45 and runs through December 31, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary contracting...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of BIKTARVY 50-200-25 MG TABLET pharmaceutical products. The firm-fixed-price delivery order, valued at $45,387.49, has a completion date of September 4, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities...
This federal contract award, valued at $37,860.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025 and is structured as a firm fixed-price delivery order. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,426.78 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET medication, with a completion date of December 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,465.30, is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract....
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKGHU
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET medical products, with a ceiling value of $17,361.85 and a completion date of January 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/18/25, 3:56 AM